Vega Clinic
Vega Clinic
タイ, バンコク
| タイ | トルコ | オーストリア | |
| 血漿交換術 | から $2,200 / 74,800฿ | から $1,200 / 40,800฿ | から $2,000 / 68,000฿ |
| 脊髄幹細胞移植術 | から $25,000 / 850,000฿ | から $30,000 / 1,020,000฿ | から $60,000 / 2,040,000฿ |
| 幹細胞療法 | から $1,800 / 61,200฿ | から $7,200 / 244,800฿ | から $8,500 / 289,000฿ |
Board-certified physiatrist (Diplomate of the Thai Board of Rehabilitation Medicine, 2023). Head of Rehabilitation at King Mongkut Chaokhunthahan Hospital. CEO and Founder of PYONG Rehabilitation Group since 2023.
Clinical focus: neurorehabilitation, geriatric rehabilitation, and chronic pain. Uses robotics and wearable exoskeleton gait training. Performs ultrasound-guided procedures and advanced laser and radiofrequency therapies.
Principal Investigator of a pilot randomized controlled trial on wearable exoskeleton gait training in subacute stroke. Presented to the Royal College of Physiatrists of Thailand in 2023. Instructor at KMITL since 2020.
Completed Rehabilitation Medicine residency at Chulalongkorn University in 2023. Earned an MD in 2017. Runs a public health platform with over 100,000 followers. Hosted PYONG SUMMIT in 2024 with over 200 attendees. Honors include nominee for Quality Person of the Year 2025 and First Prize in the Ananda Mahidol Pin Design in 2016.
Dr. Tara Rak-areekul is a neurologist focused on cognitive neurology. She is a fellow at King Chulalongkorn Memorial Hospital. She completed her neurology residency there and served as Chief of Academic in 2023. She holds an MD from Chulalongkorn University (Second Class Honors) and a Higher Graduate Diploma in Clinical Sciences. She is certified in NIHSS (2022) and the Thai Stroke Society Acute Stroke Treatment Course.
Key achievements include first rank in the National Formative Neurological Exam (2023). She won the Epilepsy Quiz Tournament (2023). She was first runner-up at the Neurology Tournaments at NST Midyear 2023 and the Chula Neuroscience Forum 2022. Her research includes AAIC poster presentations (2024, 2025). Ongoing work covers Alzheimer’s biomarkers (MDS‑OAβ and p‑tau217), the Thai clinical adaptation of HippoCamera, and a chapter on behavioral and psychological symptoms of dementia (BPSD).
Primary ALS treatment in Thailand focuses on multidisciplinary care at JCI-accredited facilities in Bangkok. Patients access FDA-approved medications like Riluzole alongside supportive therapies for respiratory and motor management. Modern protocols often integrate neurorehabilitation with advanced technologies like robotic gait training and mesenchymal stem cell applications.
Bookimed Expert Insight: While many search for experimental stem cell treatments, the real value in Thailand lies in its neurorehabilitation infrastructure. Facilities like Bumrungrad International Hospital serve over 500,000 international patients annually. They combine high-end technology with intensive physical therapy. Choosing a package that includes multiple nights of hospitalization allows for better initial monitoring of drug tolerance.
Patient Consensus: Patients emphasize the need to verify stem cell claims and suggest focusing on palliative support like ventilation. They recommend consulting neurologists at large private hospitals because these centers match international standards for standard ALS medication and nutrition support.
Stem cell therapy for ALS in Thailand aims to slow disease progression and improve quality of life. Clinics utilize mesenchymal stem cells for their neuroprotective properties. While considered experimental, these treatments are available at JCI-accredited facilities in Bangkok using intravenous and intrathecal delivery methods.
Bookimed Expert Insight: Success in Thailand often depends on combining cell therapy with intensive rehabilitation. Our data shows specialized centers like PYONG Rehabilitation Group focus on robotic gait training and neurorehabilitation. Choosing centers that integrate these technologies rather than standalone cell injections often leads to better functional stability. Dr. Kantaphong Thongrong at PYONG specifically uses wearable exoskeletons to maintain mobility during the treatment window.
Patient Consensus: Patients note that while the treatment may offer a temporary boost in energy, it is vital to manage expectations. Many stress the importance of following a strict neurorehabilitation routine afterward to maintain any motor function improvements gained during the trip.
Leading Thai hospitals like Bumrungrad International and Chulalongkorn Memorial provide recognized ALS care through specialized neuroscience departments. These facilities offer multidisciplinary support including neurology, rehabilitation, and palliative services. JCI-accredited centers in Bangkok utilize advanced imaging and international protocols to manage neurodegenerative symptoms.
Bookimed Expert Insight: While many search for experimental therapies, the real value in Thailand is the recovery infrastructure. Specialized providers like PYONG Rehabilitation Group focus on robotic gait training and hydrodissection. These advanced therapies help maintain mobility longer than standard physical therapy alone. This infrastructure is often more accessible in Bangkok than in many Western cities.
Patient Consensus: Patients note that navigating Bangkok traffic with limited mobility is difficult. Many suggest organizing home-based physiotherapy or choosing hospitals with inclusive transfers to minimize physical strain.
International patients choose Thailand for ALS management to access mesenchymal stem cell (MSC) therapies often unavailable in Western countries. Facilities like Bumrungrad International Hospital combine JCI-accredited neurology with advanced robotics. Many programs integrate neurorehabilitation, wearable exoskeleton training, and specialist-led palliative care protocols.
Bookimed Expert Insight: While many seek Thailand for experimental stem cell infusions, the real value lies in the integrated neurorehabilitation. Dr. Kantaphong Thongrong at PYONG Rehabilitation Group leads clinical use of wearable exoskeletons. This robotic gait training is rarely bundled with regenerative treatments elsewhere. Patients should prioritize clinics that offer these physical sessions alongside MSC therapy to maximize mobility outcomes.
Patient Consensus: Patients value Thailand for compassionate and low-stress palliative support. However, they strongly recommend verifying any clinic's success claims against international clinical trial databases before traveling for experimental stem cell procedures.
Thailand offers ALS treatment through mesenchymal stem cell (MSC) therapy and neurological rehabilitation. Major centres like Bumrungrad International provide standard medication like Riluzole. Specialist clinics such as EDNA Wellness and PYONG Rehabilitation Group focus on neuroprotection and intensive robotic gait training.
Bookimed Expert Insight: Many patients seek single injections. However, our data shows a trend toward multi-day protocols. Clinics like Vega Clinic offer stays up to 45 days. This allows for intensive monitoring alongside stem cell administration. Choosing clinics with 5-star hotel inclusions can simplify logistics for patients with mobility challenges.
Thai clinics manage respiratory failure from Amyotrophic lateral sclerosis (ALS) using international standards. These include non-invasive ventilation (NIV) and airway clearance. Major centres in Bangkok provide BiPAP machines alongside JCI-accredited care. Specialists work in multidisciplinary teams including neurologists and respiratory physios.
Bookimed Expert Insight: Many local clinics focus on regenerative therapies. However, patients with complex ALS symptoms should look for hospitals with integrated rehabilitation units. Dr Kantaphong Thongrong at PYONG Rehabilitation Group specialises in neurorehabilitation and robotic gait training. This specialist physiatry is essential for managing secondary ALS complications beyond just respiratory support.
Stem cell therapies for ALS are widely available in private Thai clinics. Providers use mesenchymal and umbilical cord stem cells to manage disease progression. These protocols often include intravenous drips or lumbar punctures. Major centres in Bangkok also integrate neurorehabilitation into treatment plans.
Bookimed Expert Insight: Thai clinics often bundle stem cell therapy with diagnostic testing. A typical package at ID Clinic Bangkok includes blood tests, chest X-rays, and preoperative screenings. This thorough assessment helps doctors tailor the high-dose MSC treatments. These can reach 80 million cells per session.
Patient Consensus: Patients consider these therapies as experimental rather than standard care. They recommend confirming if protocols have ethical oversight. Patients should discuss all overseas options with an Australian neurologist before travel.
Thailand clinics primarily manage ALS using Riluzole and Edaravone to slow functional decline. JCI-accredited facilities in Bangkok combine these with neurorehabilitation and mesenchymal stem cell therapies. Specialist neurologists oversee care to manage symptoms like spasticity and cramps alongside respiratory support.
Bookimed Expert Insight: Thailand combines standard pharmaceutical care with regenerative treatments. Major hospitals like Bumrungrad specialise in standard neurology. Boutique centres like EDNA Wellness and Plenary Wellness often partner with university laboratories. These partnerships allow them to offer mesenchymal stem cells. This provides a multi-layered approach that is harder to find in many other regions.
Patient Consensus: Patients in Thailand recommend checking if Riluzole and Edaravone are stocked locally. Some hospitals may require pre-ordering. They note that successful care depends on combining these drugs with feeding support and respiratory planning.
ALS care in Thailand involves a multidisciplinary diagnostic process at JCI-accredited hospitals like Bumrungrad International. Specialists use electromyography (EMG) and nerve conduction studies to confirm motor neuron loss. They also perform brain and spinal MRI scans and extensive blood work to rule out conditions that mimic ALS.
Bookimed Expert Insight: Major hospitals provide standard diagnostics. However, specialised clinics like EDNA Wellness partner with GMP-certified laboratories for regenerative research. This allows patients to combine definitive diagnostics with stem cell-based supportive care protocols. These facilities often provide teleconsultations for Australians to review their case before travelling.
Rehabilitation for ALS in Thailand uses a multidisciplinary approach at JCI-accredited centres. Specialists provide neuro-rehabilitation through physiotherapy, respiratory care, and robotic gait training. Facilities like PYONG Rehabilitation Group offer wearable exoskeletons. Regenerative therapies using mesenchymal stem cells are also common.
Bookimed Expert Insight: Thai rehabilitation clinics often integrate university-led research into patient care. Plenary Wellness collaborates with Prince of Songkla University on regenerative protocols. This provides patients access to research-backed mesenchymal stem cell dosages. These often range from 20 million to 80 million cells per session.